Evaluation of three automated systems for susceptibility testing of enterobacteria containing qnrB, qnrS, and/or aac(6′)-Ib-cr

Journal of Clinical Microbiology

Volumn 49, Issue 9, 2011, Pages 3343-3345

  Calvo, Jorge ^a   Cano, María Eliecer ^a   Pitart, Cristina ^b   Marco, Francesc ^b   Rodríguez Martínez, José Manuel ^c,d   Pascual, Álvaro ^c,d   Martínez Martínez, Luis ^a,e  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^e UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; TOBRAMYCIN;

AAC(6') IB CR GENE; ACCURACY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BROTH DILUTION; CONTROLLED STUDY; ENTEROBACTERIACEAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QNRB GENE; QNRS GENE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; AUTOMATION; DIAGNOSTIC ERRORS; ENTEROBACTERIACEAE; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; QUINOLONES;

ENTEROBACTERIACEAE;

EID: 80052194687     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00563-11     Document Type: Article

References (13)

1. Cano, M. E., et al. 2009. Detection of plasmid-mediated quinolone resistance genes in clinical isolates of Enterobacter spp. in Spain. J. Clin. Microbiol. 47:2033-2039.
2. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; 8th ed. Approved standard. CLSI document M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Doern, G. V., B. B. Torres, M. Jankins, and R. N. Jones. 1996. Accurate characterization of ofloxacin susceptibility with Enterobacteriaceae using a modified GNS F6 card and the bioMerieux Vitek System. Diagn. Microbiol. Infect. Dis. 25:133-135.
5. Martínez-Martínez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799.
6. Martínez-Martínez, L., M. E. Cano, J. M. Rodríguez-Martínez, J. Calvo, and A. Pascual. 2008. Plasmid-mediated quinolone resistance. Expert Rev. Anti Infect. Ther. 6:685-711.
7. Menozzi, M. G., et al. 2006. Two-center collaborative evaluation of performance of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Gram-negative bacteria. J. Clin. Microbiol. 44:4085-4094.
8. Piddock, L. J. V. 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19:382-402.
9. Rittenhouse, S. F., L. A. Miller, L. J. Utrup, and J. A. Poupard. 1996. Evaluation of 500 Gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents. Diagn. Microbiol. Infect. Dis. 26:1-6.
10. Rodríguez-Martínez, J. M., M. E. Cano, C. Velasco, L. Martínez-Martínez, and A. Pascual. 2011. Plasmid-mediated quinolone resistance: an update. J. Infect. Chemother. 17:149-182.
11. Rodríguez-Martinez, J. M., et al. 2005. Evaluation of antimicrobial susceptibility of bacteria containing the qnr gene and FOX-5 beta-lactamase by four automated systems. Clin. Microbiol. Infect. 11:402-404.
12. Sanders, C. C., et al. 2001. Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital. J. Clin. Microbiol. 39:2379-2385.
13. U.S. Food and Drug Administration. 2003. Class II special controls guidance document: antimicrobial susceptibility test (AST) systems; guidance for industry and FDA. U.S. Food and Drug Administration, Rockville, MD.